Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Excursion to Different Universes: the Top Sci-fi Motion pictures Ever - 2Chinese astronauts’ return to Earth delayed over fears spaceship damaged by debris
- 3From Exemplary to Current: Famous Rings Available
- 4British-Egyptian dissident apologises for tweets as Tories push for UK deportation
- 5Russian authorities threaten WhatsApp with total ban
- Amateur's Manual for Venture Strategies for Tenderfoots
- Father and son spending Christmas together after health scares
- A rare whale is having an encouraging season for births. Scientists warn it might still go extinct
- IDF destroys two-kilometer-long Gaza terror tunnel in Beit Lahiya
- 6 Methods for further developing Rest Quality
- Between 600 to 800 aid trucks entering Gaza daily since start of ceasefire, COGAT confirms
- Vote In favor of Your Favored IT Administration
- NASA will bring space station crew home early after medical issue
- Find Unexpected, yet invaluable treasure Excursion Rentals
